Large-scale testing (Phase 3)Study completedNCT00004939
What this trial is testing
Phase III Randomized, Double-Blind, Placebo-Controlled Study of 3,4-Diaminopyridine for Demyelinating Polyneuropathy
Who this might be right for
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
National Center for Research Resources (NCRR) 34